On Friday, Wolfe Research made adjustments to its Alpha List, adding Alpine Immune Sciences (NASDAQ:ALPN), Corteva (NYSE:NYSE:CTVA), and CVS Health (NYSE:NYSE:CVS) to the roster. Concurrently, Humana (NYSE:NYSE:HUM) was taken off the list. The Alpha List is a compilation akin to Goldman Sachs (NYSE:GS)' Director Cut list, where stocks are included or removed based on the investment thesis of the analysts.
Alpine Immune Sciences, a company focused on developing innovative treatments for cancer and autoimmune diseases, was one of the new entrants. The inclusion of Alpine may reflect Wolfe Research's positive outlook on the company's potential in its field.
Corteva, a major player in the agricultural science and technology sector, also earned a spot on the list. This addition could signal confidence in Corteva's growth prospects or its position within the agricultural industry.
CVS Health, a health services and retail company, was another addition to the Alpha List. The company's placement on the list might suggest an anticipation of strong performance or strategic moves that could benefit its stock value.
The removal of Humana, a health insurance provider, from the Alpha List indicates a shift in the investment thesis regarding the company. This change could be attributed to various factors, including market performance, sector changes, or company-specific developments.
Wolfe Research's Alpha List is a resource for investors, providing insight into the stocks the firm's analysts believe have significant potential. The recent updates reflect the ongoing analysis and adjustments made by Wolfe Research as market conditions and company performances evolve.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.